Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 372 participants.

Also called NCT07668323

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 372 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07668323
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07668323. Randomized; single masking; primary purpose treatment. Start 2026-09-19 (actual); primary completion 2029-01-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion
Acronym
IAT-MEVO
Condition
Medium Vessel Occlusion
Condition
Ischemic Stroke, Acute
Intervention (Drug)
Recombinant Tissue Plasminogen Activator (rt-PA)
Intervention (Procedure)
Intra-arterial Thrombolysis
Intervention (Drug)
Best Medical Management
Intervention (Procedure)
Rescue therapy
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University (class: other)

Record details

Record id
cardio:ct-nct07668323
Content hash
121c782009182ae2e477b0eda95b99202101db73e936d63bcb501e13177eedbc